Introduction
Bladder cancer poses a significant worldwide health problem, with an estimated 68 810 new cases and 14 100 deaths in the USA in 2008 alone (1) . In China, it accounts for the 10th most common cancer, with 17 365 deaths in 2005 (2) . It has been established that tobacco smoking and occupational exposure to chemical carcinogens are the strongest risk factors for bladder cancer (3) . Although many people are exposed to these risk factors, only a part of them develop bladder cancer in their life time, suggesting genetic susceptibility to bladder carcinogenesis may vary in the general population.
Prostate stem cell antigen (PSCA) was initially identified as a prostate-specific cell-surface antigen (4) . PSCA is largely expressed in normal prostate and overexpressed in a majority of prostate cancer. There is also expression of PSCA in extraprostatic normal tissues, such as bladder, esophagus, stomach, pancreas, kidney, etc. (5) (6) (7) . PSCA is highly expressed in other non-prostatic malignancies, including bladder, clear renal cell, gestational trophoblastic and pancreatic tumors, analogous to prostate cancer (7) (8) (9) (10) .
To date, the precise function of PSCA remains unknown. Many studies have evaluated the relationship between PSCA and risk of various cancers. Gu et al. (11) reported that the increased level of PSCA expression was correlated with tumor grade, stage and androgen independence in prostate cancer, and PSCA might be a molecular marker for the progression of prostate tumor. Conversely, in gastric cancer, relatively decreased expression level of PSCA was associated with susceptibility to malignancies suggestive of a tumor suppressorlike character (12) . The exact role of PSCA in bladder cancer is still not clear. It is contradictory between the results of Amara et al. (13) and Bahrenberg et al. (5) on the association of PSCA expression level and risk of bladder cancer. Cheng et al. (14) employed PSCA antigen as an adjunct marker for the detection of urothelial transitional cell carcinoma in voided urine specimens. It is also suggested that PSCA could be a valuable prognostic marker for recurrence in superficial bladder cancer (8) .
Recently, a two-stage genome-wide association study (GWAS) conducted by Sakamoto et al. (12) in Japan had identified a significant association of rs2294008 (C.T), in exon 1 of the PSCA gene with diffuse-type gastric cancer in both Japanese and Korean populations. Two studies performed subsequent to that GWAS have ascertained significance of association between rs2294008 and gastric cancer risk in Japan and China (15, 16) . Intriguingly, another recently published GWAS on the association between rs2294008 and bladder cancer risk further identified rs2294008 to confer susceptibility to bladder cancer in Caucasians (17) . Given the consistent and important role of PSCA involved in susceptibility to bladder cancer and the attractive statistical significance of rs2294008 in the two GWAS, we hypothesized that rs2294008 is associated with risk of bladder cancer in Chinese populations and may be served as a prognostic marker.
Materials and methods

Study subjects
This study comprised 581 cases with histologically confirmed transitional cell carcinoma of bladder and 580 cancer-free controls. Study subjects recruited in our study have been described previously (18, 19) . Patients who had previous cancer, metastasized cancer from other origin, previous radiotherapy or chemotherapy were excluded. The rate of participation was $95%. All controls, recruited from those who accompanied the patients or who were seeking for health care, were genetically unrelated to cases and frequency-matched to cases by age (±5 years) and sex. The exclusion criteria for the controls were significant mental impairment or blood transfusion in the past months; controls were also excluded if they had symptoms suggestive of bladder cancer, such as hematuria. The response rate of controls in the present study is .85%. Each eligible subject was interviewed face-to-face for demographic information as well as data on smoking status. People who smoked daily for .1 year were defined as ever-smokers. Ever-smokers who had quit smoking for .1 year were defined as former smokers and the others as current smokers. We also conducted pack-years calculation: [(cigarettes per day/20) Â years smoked] to indicate the cumulative smoking dose. All cases pathological diagnosis for tumor stage was according to the 2002 International Union Against Cancer (UICC) tumor-nodes-metastasis classification and for grade as the World Health Organization 1973 grading of urothelial papilloma: well differentiated (grade 1, G1), moderately differentiated (grade 2, G2) or poorly differentiated (grade 3, G3). After having signed informed consent, each subject donated 5 ml of blood for genomic DNA extraction. Institutional review board of Nanjing Medical University approved the research protocol.
Genotyping
Genomic DNA was isolated from peripheral blood lymphocytes. The polymorphism was determined by polymerase chain reaction (PCR)-restriction fragment length polymorphism method. The primers were forward: 5#-CCA-CAGCCCACCAGTGACCA-3# and reverse: 5#-CCTGCAGGTATCCTCTG-GCCT-3#. The generated DNA fragments of 143 bp were digested by the Hin1II restriction enzyme (New England Biolabs, Beverly, MA) to determine genotypes of rs2294008. The genotype analysis was performed by two persons separately in a blind fashion. A 10% masked samples were randomly selected for confirmation, and the results were 100% concordant.
Analysis of PSCA messenger RNA To further explore the correlation between the PSCA messenger RNA (mRNA) levels and rs2294008 in vivo, 16 normal bladder tissues adjacent to tumors Abbreviations: CI, confidence interval; GWAS, genome-wide association study; mRNA, messenger RNA; OR, odds ratio; PCR, polymerase chain reaction; RT, reverse transcription. were utilized to isolate total RNA using Trizol Reagent (Invitrogen, Carlsbad, CA) for real-time quantitative reverse transcription (RT)-PCR analysis. The detailed method for real-time quantitative RT-PCR was described previously (20) . The primers have been described previously (21) .
Statistical analysis
We used v 2 -test to compare the differences in the distributions of demographic characteristics, selected variables and genotypes between cases and controls. Hardy-Weinberg equilibrium of the controls' genotype frequencies was tested by a goodness of fit v 2 test. Unconditional univariate and multivariate logistic regression was applied to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to estimate the association between the polymorphism and risk of bladder cancer, with adjustment for age, sex and tobacco smoking. A morethan-multiplicative gene-environment interaction was assessed by logistic regression analysis, including main effect variables and their product terms. For mRNA quantitative analysis, the relative measures of gene expression (2 ÀDCT ) measured using real-time quantitative RT-PCR were compared with unpaired t-test (Mann-Whitney test) on log-transformed value (10) . Power for individual single nucleotide polymorphism was calculated using Quanto (http://hydra.usc.edu.gxe). All analyses were performed using SAS (version 9.1.3; SAS Institute) and all tests were two sided.
Results
Characteristics of the study subjects The frequency distributions of demographic characteristics of the cases and controls are shown in Table I . There was no difference in the distribution of age (P 5 0.805) or sex (P 5 0.703) between the cases and controls. Nevertheless, there were more ever-smokers (55.4%) among the cases than among the controls (36.2%), and the difference was statistically significant (P , 0.001). Thereafter, these variables were adjusted for in the subsequent multivariate logistic regression analysis.
Association between PSCA rs2294008 and bladder cancer risk The allele and genotype frequencies of rs2294008 among the cases and controls and their association with bladder cancer risk are presented in Table II . The genotype frequencies in the controls were consistent with those expected from the Hardy-Weinberg equilibrium model (v 2 5 0.439, P 5 0.508).
When we used the CC genotype as the reference, we found that the CT, but not TT, genotype was associated with an increased risk of bladder cancer (adjusted OR, 1.39; 95% CI, 1.09-1.78 for CT genotype and adjusted OR, 1.33; 95% CI, 0.85-2.08 for TT genotype). Considering relatively scarce frequencies of TT genotype, and similar scales of the ORs for heterozygote and risk homozygote the equality of that tested to observe a non-significant P-value of 0.865 suggesting a dominant model, we combined CT and TT genotypes as a dominant genetic model in the following association analysis, and the combined CT/TT genotypes conferred a statistically significantly increased risk of bladder cancer (adjusted OR, 1.38; 95% CI, 1.09-1.75) (Table II) .
Association between PSCA rs2294008 and progression of bladder cancer The association between PSCA rs2294008 and pathological grade and clinical stage of bladder cancer was further evaluated. As shown in Table III , a significantly increased risk was found in individuals with risk T allele in grade 2 (OR, 1.43; 95% CI, 1.05-1.96) and invasive stage (OR, 1.65; 95% CI, 1.18-2.31) of bladder cancer. Although we did not find any significant associations with bladder cancer with grade 1 (OR, 1.31; 95% CI, 0.97-1.77) and grade 3 (OR, 1.37; 95% CI, 0.88-2.14), and superficial bladder cancer (OR, 1.25; 95% CI, 0.96-1.63), the estimates were consistent with the main effects, which may be due to fewer numbers in these strata.
Interaction between PSCA rs2294008 and tobacco smoking Compared with non-smokers with the CC genotype, a statistically significantly increased risk was observed in smokers with CC and CT/TT genotypes (OR, 2.20; 95% CI, 1.55-3.10, P , 0.001 and OR, 3.44; 95% CI, 2.41-4.91, P , 0.001, respectively) (Table IV) . Because risk T allele exerted a higher risk effect in smokers, we evaluated whether there was existence of an interaction between smoking status and the PSCA polymorphism. Nevertheless, we did not observe a multiplicative interaction between the polymorphism and smoking status (P 5 0.309) ( Table IV) .
Correlation of rs2294008 with the PSCA mRNA expression Sixteen normal bladder tissues adjacent to tumors had different genotypes of PSCA polymorphism, and the frequency distribution of the CC, CT and TT genotypes was 8, 7 and 1, respectively. We further assessed the association between the PSCA polymorphism and mRNA expression levels using quantitative real-time RT-PCR ( Figure 1 ). The sole sample with TT genotype was added to the samples of CT genotype for analysis, and statistically significant lower PSCA mRNA expression was identified in samples with CT/TT genotypes compared with samples with CC genotype (P , 0.001). These results were consistent with the published data by Sakamoto et al. (12) and further supported the association between the CT/TT genotypes and a decreased PSCA mRNA expression. 
Discussion
PSCA rs2294008 polymorphism was initially identified in a GWAS as a susceptibility variation in the PSCA gene for diffuse-type gastric cancer in Japanese and Korean populations (12) , and the results were validated in other two independent studies (15, 16) . In the present study, we evaluated the association of rs2294008 with risk of bladder cancer in Chinese populations. With similar results in the GWAS (12) that risk T allele is related to the increased risk of gastric cancer, the genotypes carrying risk T allele also contributed to the increased bladder cancer risk and the result was consistent with another recently published data (17) .
It is notable that in the GWAS conducted in Japan (12), the rs2294008 T allele existed as major allele (minor allele frequency 5 0.62, based on HapMap database) in Japanese and as a risk allele for diffuse-type gastric cancer susceptibility, whereas the same allele represented minor allele (minor allele frequency 5 0.46) in Caucasians and risk allele for bladder cancer carcinogenesis (17) . The frequency of T allele in Chinese was even lower than Caucasians (minor allele frequency 5 0.26); nevertheless, it exerted a resemble role in bladder cancer susceptibility in Chinese as Caucasians. The population genetic history of this single nucleotide polymorphism and why Japanese possess a different minor allele remain to be explained (17) .
Subgroup analysis according to tumor grade and stage may help in identifying prognostic factors involved in different bladder cancer progression pathways (22) . Stratification analyses demonstrated that the rs2294008 was significantly associated with invasive bladder cancer. It has been postulated that superficial and invasive bladder carcinomas have different pathological mechanisms of carcinogenesis involving different genetic and epigenetic defects (23) . This finding should be interpreted with caution and validated in larger studies in Chinese populations, as our sample size was relatively small and another recently published GWAS reported that the association was similar in superficial and invasive bladder cancer in US populations (17) .
There are hundreds of chemicals in tobacco smoke, some of which are known carcinogens, such as polycyclic aromatic hydrocarbons and N-nitroso compounds (24) . It has been reported that a positive doseresponse relationship in increased risk associated with increased both smoking years and number of cigarettes smoked daily is implicated in the etiology of bladder cancer (22) . In this study, we did not find multiplicative joint effect between the PSCA rs2294008 polymorphism and risk of bladder cancer among smokers, which may be due to the small sample size that did not have enough power to detect it.
Sakamoto et al. (12) reported that substitution of the C allele with T allele at rs2294008 reduces transcriptional activity of an upstream fragment of PSCA. In vitro reporter assays conducted by Wu et al. (17) further confirmed that the T allele reduced the transcriptional activity of the PSCA promoter in bladder cancer cells. In the present study, using quantitative real-time RT-PCR method, we found that the PSCA polymorphism and bladder cancer risk normal tissues adjacent to tumors with T allele had relatively weak expression of PSCA mRNA than those with C allele, which might indirectly validate the finding that T allele can reduce the transcriptional activity of PSCA in bladder tissues. However, this experiment needed to be done in normal bladder tissues and with large sample size. One possible biological mechanism underlying the rs2294008 polymorphism associated with the increased bladder cancer risk is that the T allele reduced the transcriptional activity of the PSCA gene since PSCA has been suggested to have a tumor suppressor-like character (12) and related to the adhesion of cells (5, 25) . However, as PSCA maps to chromosome 8q24.2 and the biological mechanisms of all the previously identified cancer susceptibility variants in 8q24 remain elusive (17) , further functional studies are need to uncover the pathological mechanisms underlying the association of rs2294008 of PSCA and bladder carcinogenesis.
Some limitations may exist in the present study. One is that our study was a hospital-based case-control study, so we can not exclude the chance of selection bias. Nevertheless, the T allele frequency in control subjects is close to that reported in HapMap database for Han Chinese in Beijing (CHB) (0.266 in our study versus 0.256 in HapMap database). Another limitation is our relatively small sample size, with 581 cases and 580 controls. However, we have 81% power to detect a minimal OR of 1.3 with an exposure frequency of 25% under the current sample size. Specially, recent published GWAS on the association between rs2294008 and bladder cancer risk performed by Wu et al. (17) identified that the OR for individuals with CT was 1.30 (95% CI, 1.18-1.42), 1.40 (95% CI, 1.25-1.56) for TT carriers and 1.33 (95% CI, 1.22-1.56) for individuals with at least one risk T allele (CT/TT), which was compatible with our results with OR 5 1.39 (95% CI, 1.09-1.78) for CT, 1.33 (95% CI, 0.85-2.08) for TT and 1.38 (95% CI, 1.09-1.75) for CT/TT carriers.
In conclusion, the PSCA rs2294008 polymorphism was associated with risk of bladder cancer in Chinese populations and might play a role in bladder cancer initiation and progression, suggesting that rs2294008 may be a useful diagnostic marker for genetic susceptibility to bladder cancer. Larger samples and functional studies are warranted to describe the fundamental effect of PSCA and delineate the biological mechanisms inherent in the association of rs2294008 with bladder tumorigenesis. 
